Prevalence of Ocular Surface Disease in Glaucoma Patients
Completed
- Conditions
- Glaucoma
- Registration Number
- NCT00382122
- Lead Sponsor
- Alcon Research
- Brief Summary
Demographic information and a brief medical and concomitant medicine history will be obtained from the glaucoma patient's records. Qualified patients will be asked to complete a questionnaire about their symptoms. Patients will then be scheduled to undergo three standard clinical tests of the ocular surface.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 101
Inclusion Criteria
- Diagnosis of glaucoma;
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria
- Inability to understand trial procedures;
- Inability to understand Informed Consent;
- Current use or use within the last 3 months of Restasis, steroids, or topical ocular non-steroidal anti-inflammatory drugs;
- Punctal plugs;
- Previous glaucoma, corneal, or conjunctival surgery;
- Other protocol-defined exclusion criteria may apply.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link ocular surface disease to glaucoma progression in NCT00382122?
How does the prevalence of ocular surface disease in glaucoma patients compare to standard-of-care treatment outcomes?
Are there specific biomarkers identified in NCT00382122 for predicting ocular surface disease severity in glaucoma patients?
What adverse events are associated with ocular surface disease testing in glaucoma patients as reported in NCT00382122?
What combination therapies are being explored by Alcon Research for managing ocular surface disease in glaucoma patients?
Trial Locations
- Locations (1)
La Jolla
🇺🇸La Jolla, California, United States
La Jolla🇺🇸La Jolla, California, United States